Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging

被引：58
作者：
Le, DA
Lipton, SA [1 ]
机构：
[1] Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA
[2] Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Stroke & Neurovasc Regulat Lab, Boston, MA USA
来源：
DRUGS & AGING | 2001年 / 18卷 / 10期
关键词：
D O I：
10.2165/00002512-200118100-00001
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
The N-methyl-D-aspartate (NMDA) receptor complex is a subtype of glutamate receptor and its dysfunction is involved in many neurological disorders associated with aging, including chronic pain, depression, stroke and Parkinson's disease. Multiple clinical trials using NMDA receptor antagonists have been aborted mainly due to the severe psychomimetic adverse effects of these drugs that occur before concentrations can reach an adequate level in the brain. In this review, we present the evidence that clinically safer NMDA antagonists such as memantine and nitroglycerin., and the combination drug nitro-memantine, are promising as drugs in treating neurodegenerative diseases.
引用
收藏
页码：717 / 724
页数：8
相关论文
共 72 条
  • [1] New approaches to pain control in patients with cancer
    Ahmedzai, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : S8 - S14
  • [2] Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
    Alexi, T
    Borlongan, CV
    Faull, RLM
    Williams, CE
    Clark, RG
    Gluckman, PD
    Hughes, PE
    [J]. PROGRESS IN NEUROBIOLOGY, 2000, 60 (05) : 409 - 470
  • [3] Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
  • [4] APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE
    BECKMAN, JS
    BECKMAN, TW
    CHEN, J
    MARSHALL, PA
    FREEMAN, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) : 1620 - 1624
  • [5] Antidepressant effects of ketamine in depressed patients
    Berman, RM
    Cappiello, A
    Anand, A
    Oren, DA
    Heninger, GR
    Charney, DS
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (04) : 351 - 354
  • [6] Drug therapy - Treatment of acute ischemic stroke
    Brott, T
    Bogousslavsky, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10) : 710 - 722
  • [7] Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation
    Chen, HSV
    Wang, YF
    Rayudu, PV
    Edgecomb, P
    Neill, JC
    Segal, MM
    Lipton, SA
    Jensen, FE
    [J]. NEUROSCIENCE, 1998, 86 (04) : 1121 - 1132
  • [8] CHEN HSV, 1992, J NEUROSCI, V12, P4427
  • [9] Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: Uncompetitive antagonism
    Chen, HSV
    Lipton, SA
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1997, 499 (01): : 27 - 46
  • [10] GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM
    CHOI, DW
    [J]. NEURON, 1988, 1 (08) : 623 - 634
12345678